![A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m
<sup>2</sup>
Administered Weekly as a 30-Minute Intravenous Infusion in Patients With Cancer]()
A Phase I Study to Characterize the Safety, Tolerability, and Pharmacokinetics of Topotecan at 4 mg/m
<sup>2</sup>
Administered Weekly as a 30-Minute Intravenous Infusion in Patients With CancerCurtis, Kelly K.; Hartney, Jean T.; Jewell, Roxanne C.; Park, Jung W.; Lebowitz, Peter F.; Griffin, Pamela P.; Borad, Mitesh J.; Fitch, Tom R.; Northfelt, Donald W. · The Journal of Clinical Pharmacology · 2010